✦ LIBER ✦

1133 MRI-guided transurethral ultrasound ablation of prostate cancer: Preliminary outcomes of a phase I clinical trial

✍ Scribed by Billia, M.; Burtnyk, M.; Kuru, T.; Pahernik, S.; Roethke, M.; Schlemmer, H.P.; Romagnoli, C.; Chin, J.

Book ID: 122928189
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 200 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)61113-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP62-05 MAGNETIC RESONANCE IMAGING (MRI)

MP62-05 MAGNETIC RESONANCE IMAGING (MRI)-GUIDED TRANSURETHRAL ULTRASOUND ABLATION OF PROSTATE CANCER: PRELIMINARY OUTCOMES OF A PHASE I CLINICAL TRIAL

✍ Billia, Michele; Burtnyk, Mathieu; Kuru, Timur; Pahernik, Sascha; Roethke, Matth 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 174 KB

84 THE USE OF MRI-GUIDED TRANSURETHRAL U

84 THE USE OF MRI-GUIDED TRANSURETHRAL ULTRASOUND THERAPY FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PHASE I STUDY

✍ A.J. Colquhoun; H. Foster; L. Sugar; M. Haider; L.H. Klotz; M. Bronskill; R. Cho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 191 KB

1782 THE USE OF MRI-GUIDED TRANSURETHRAL

1782 THE USE OF MRI-GUIDED TRANSURETHRAL ULTRASOUND THERAPY FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER: A PHASE I STUDY

✍ Colquhoun, Alexandra; Foster, Harry; Sugar, Linda; Haider, Masoom; Klotz, Lauren 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 93 KB

UP-2.160: Treating Unilateral Localised

UP-2.160: Treating Unilateral Localised Prostate Cancer with Hemi-Ablation High Intensity Focused Ultrasound (HIFU): Results of a NCRN-Approved Phase II Focal Therapy Clinical Trial

✍ M. Sahu; H. Ahmed; S. Kumaar; N. Arumainayagam; K. Rogers; R. Scott; A. Kirkham; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Preliminary report of a multi center can

Preliminary report of a multi center canadian phase III randomized trial of 3 months vs 8 months neoadjuvant androgen ablation prior to standard dose radiotherapy for clinically localized prostate cancer

✍ J.M Crook; C Ludgate; J Lim; G Perry; S Malone; L Eapen; J Bowen; S Robertson; G 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB